nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—Blood pressure increased—Captopril—systemic scleroderma	0.0424	0.0424	CcSEcCtD
Droxidopa—Blood pressure increased—Leflunomide—systemic scleroderma	0.0349	0.0349	CcSEcCtD
Droxidopa—Blood pressure increased—Mycophenolic acid—systemic scleroderma	0.0333	0.0333	CcSEcCtD
Droxidopa—Cardiac failure congestive—Mycophenolic acid—systemic scleroderma	0.0267	0.0267	CcSEcCtD
Droxidopa—Urinary tract infection—Mometasone—systemic scleroderma	0.0262	0.0262	CcSEcCtD
Droxidopa—Arrhythmia—Pentoxifylline—systemic scleroderma	0.0251	0.0251	CcSEcCtD
Droxidopa—Hypertension—Pentoxifylline—systemic scleroderma	0.0211	0.0211	CcSEcCtD
Droxidopa—Cardiac failure congestive—Mycophenolate mofetil—systemic scleroderma	0.021	0.021	CcSEcCtD
Droxidopa—Confusional state—Pentoxifylline—systemic scleroderma	0.0201	0.0201	CcSEcCtD
Droxidopa—Shock—Pentoxifylline—systemic scleroderma	0.0196	0.0196	CcSEcCtD
Droxidopa—Urinary tract infection—Leflunomide—systemic scleroderma	0.019	0.019	CcSEcCtD
Droxidopa—Urinary tract infection—Mycophenolic acid—systemic scleroderma	0.0181	0.0181	CcSEcCtD
Droxidopa—Syncope—Captopril—systemic scleroderma	0.0166	0.0166	CcSEcCtD
Droxidopa—Arrhythmia—Azathioprine—systemic scleroderma	0.0166	0.0166	CcSEcCtD
Droxidopa—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.0164	0.0164	CcSEcCtD
Droxidopa—Urinary tract infection—Lisinopril—systemic scleroderma	0.0163	0.0163	CcSEcCtD
Droxidopa—Loss of consciousness—Captopril—systemic scleroderma	0.0163	0.0163	CcSEcCtD
Droxidopa—Arrhythmia—Leflunomide—systemic scleroderma	0.0157	0.0157	CcSEcCtD
Droxidopa—Confusional state—Captopril—systemic scleroderma	0.0152	0.0152	CcSEcCtD
Droxidopa—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.0149	0.0149	CcSEcCtD
Droxidopa—Shock—Captopril—systemic scleroderma	0.0149	0.0149	CcSEcCtD
Droxidopa—Urinary tract infection—Mycophenolate mofetil—systemic scleroderma	0.0143	0.0143	CcSEcCtD
Droxidopa—Cardiac failure congestive—Prednisone—systemic scleroderma	0.0143	0.0143	CcSEcCtD
Droxidopa—Arrhythmia—Lisinopril—systemic scleroderma	0.0135	0.0135	CcSEcCtD
Droxidopa—Dizziness—Pentoxifylline—systemic scleroderma	0.0132	0.0132	CcSEcCtD
Droxidopa—Hypertension—Leflunomide—systemic scleroderma	0.0132	0.0132	CcSEcCtD
Droxidopa—Syncope—Mycophenolic acid—systemic scleroderma	0.0131	0.0131	CcSEcCtD
Droxidopa—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.0128	0.0128	CcSEcCtD
Droxidopa—Hypertension—Mycophenolic acid—systemic scleroderma	0.0126	0.0126	CcSEcCtD
Droxidopa—Headache—Pentoxifylline—systemic scleroderma	0.0125	0.0125	CcSEcCtD
Droxidopa—Feeling abnormal—Captopril—systemic scleroderma	0.0125	0.0125	CcSEcCtD
Droxidopa—Confusional state—Mycophenolic acid—systemic scleroderma	0.012	0.012	CcSEcCtD
Droxidopa—Nausea—Pentoxifylline—systemic scleroderma	0.0118	0.0118	CcSEcCtD
Droxidopa—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.0118	0.0118	CcSEcCtD
Droxidopa—Syncope—Lisinopril—systemic scleroderma	0.0118	0.0118	CcSEcCtD
Droxidopa—Shock—Mycophenolic acid—systemic scleroderma	0.0117	0.0117	CcSEcCtD
Droxidopa—Loss of consciousness—Lisinopril—systemic scleroderma	0.0115	0.0115	CcSEcCtD
Droxidopa—Feeling abnormal—Azathioprine—systemic scleroderma	0.0109	0.0109	CcSEcCtD
Droxidopa—Confusional state—Lisinopril—systemic scleroderma	0.0108	0.0108	CcSEcCtD
Droxidopa—Headache—Mometasone—systemic scleroderma	0.0108	0.0108	CcSEcCtD
Droxidopa—Shock—Lisinopril—systemic scleroderma	0.0105	0.0105	CcSEcCtD
Droxidopa—Syncope—Mycophenolate mofetil—systemic scleroderma	0.0103	0.0103	CcSEcCtD
Droxidopa—Feeling abnormal—Leflunomide—systemic scleroderma	0.0103	0.0103	CcSEcCtD
Droxidopa—Nausea—Mometasone—systemic scleroderma	0.0102	0.0102	CcSEcCtD
Droxidopa—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.0101	0.0101	CcSEcCtD
Droxidopa—Dizziness—Captopril—systemic scleroderma	0.00999	0.00999	CcSEcCtD
Droxidopa—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00992	0.00992	CcSEcCtD
Droxidopa—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00979	0.00979	CcSEcCtD
Droxidopa—Headache—Captopril—systemic scleroderma	0.00947	0.00947	CcSEcCtD
Droxidopa—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00945	0.00945	CcSEcCtD
Droxidopa—Shock—Mycophenolate mofetil—systemic scleroderma	0.00922	0.00922	CcSEcCtD
Droxidopa—Nausea—Captopril—systemic scleroderma	0.00898	0.00898	CcSEcCtD
Droxidopa—Feeling abnormal—Lisinopril—systemic scleroderma	0.00882	0.00882	CcSEcCtD
Droxidopa—Dizziness—Azathioprine—systemic scleroderma	0.00872	0.00872	CcSEcCtD
Droxidopa—Headache—Azathioprine—systemic scleroderma	0.00826	0.00826	CcSEcCtD
Droxidopa—Dizziness—Leflunomide—systemic scleroderma	0.00824	0.00824	CcSEcCtD
Droxidopa—Arrhythmia—Prednisone—systemic scleroderma	0.00799	0.00799	CcSEcCtD
Droxidopa—Dizziness—Mycophenolic acid—systemic scleroderma	0.00786	0.00786	CcSEcCtD
Droxidopa—Nausea—Azathioprine—systemic scleroderma	0.00783	0.00783	CcSEcCtD
Droxidopa—Headache—Leflunomide—systemic scleroderma	0.0078	0.0078	CcSEcCtD
Droxidopa—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00773	0.00773	CcSEcCtD
Droxidopa—Headache—Mycophenolic acid—systemic scleroderma	0.00744	0.00744	CcSEcCtD
Droxidopa—Nausea—Leflunomide—systemic scleroderma	0.0074	0.0074	CcSEcCtD
Droxidopa—Dizziness—Lisinopril—systemic scleroderma	0.00708	0.00708	CcSEcCtD
Droxidopa—Nausea—Mycophenolic acid—systemic scleroderma	0.00706	0.00706	CcSEcCtD
Droxidopa—Syncope—Prednisone—systemic scleroderma	0.00698	0.00698	CcSEcCtD
Droxidopa—Loss of consciousness—Prednisone—systemic scleroderma	0.00684	0.00684	CcSEcCtD
Droxidopa—Hypertension—Prednisone—systemic scleroderma	0.00672	0.00672	CcSEcCtD
Droxidopa—Headache—Lisinopril—systemic scleroderma	0.0067	0.0067	CcSEcCtD
Droxidopa—Nausea—Lisinopril—systemic scleroderma	0.00636	0.00636	CcSEcCtD
Droxidopa—Shock—Prednisone—systemic scleroderma	0.00625	0.00625	CcSEcCtD
Droxidopa—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.0062	0.0062	CcSEcCtD
Droxidopa—Headache—Mycophenolate mofetil—systemic scleroderma	0.00587	0.00587	CcSEcCtD
Droxidopa—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00557	0.00557	CcSEcCtD
Droxidopa—Confusional state—Methotrexate—systemic scleroderma	0.00536	0.00536	CcSEcCtD
Droxidopa—Feeling abnormal—Prednisone—systemic scleroderma	0.00524	0.00524	CcSEcCtD
Droxidopa—Feeling abnormal—Methotrexate—systemic scleroderma	0.00438	0.00438	CcSEcCtD
Droxidopa—Dizziness—Prednisone—systemic scleroderma	0.0042	0.0042	CcSEcCtD
Droxidopa—Headache—Prednisone—systemic scleroderma	0.00398	0.00398	CcSEcCtD
Droxidopa—Nausea—Prednisone—systemic scleroderma	0.00378	0.00378	CcSEcCtD
Droxidopa—Dizziness—Methotrexate—systemic scleroderma	0.00351	0.00351	CcSEcCtD
Droxidopa—Headache—Methotrexate—systemic scleroderma	0.00333	0.00333	CcSEcCtD
Droxidopa—Nausea—Methotrexate—systemic scleroderma	0.00315	0.00315	CcSEcCtD
